Strides Pharma Science Ltd

Strides Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Strides Pharma Science Ltd

₹ 1,485 -6.87%
04 Dec 2:08 p.m.
strides.com BSE: 532531 NSE: STAR
About

Strides Pharma Science Ltd is in the business of development and manufacturing of pharmaceutical products.[1] The company's pharmaceutical products are sold in over 100 countries.[2]
The company has always followed an inorganic growth strategy over the years that resulted in foray into new markets, addition of new business segments, therapy segments and manufacturing infrastructure.[3]

Key Points

About[1]
Incorporated in 1990, Strides operates in the pharmaceutical industry, manufacturing generic formulations in various dosage forms.

Website BSE NSE
  • Market Cap ₹ 13,656 Cr.
  • Current Price ₹ 1,485
  • High / Low ₹ 1,675 / 482
  • Stock P/E 174
  • Book Value ₹ 382
  • Dividend Yield 0.16 %
  • ROCE 4.83 %
  • ROE 2.02 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has been maintaining a healthy dividend payout of 108%

Cons

  • Stock is trading at 4.02 times its book value
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 6.97% over past five years.
  • Tax rate seems low
  • Company has a low return on equity of 2.61% over last 3 years.
  • Promoters have pledged 49.2% of their holding.
  • Company has high debtors of 256 days.
  • Promoter holding has decreased over last 3 years: -3.76%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Part of Nifty Total Market BSE SmallCap BSE Allcap BSE Healthcare Nifty Microcap 250

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
575 440 456 423 481 387 564 475 553 520 618 586 610
528 436 438 484 487 341 444 420 514 454 527 520 547
Operating Profit 47 4 18 -61 -6 46 119 56 38 66 91 66 63
OPM % 8% 1% 4% -14% -1% 12% 21% 12% 7% 13% 15% 11% 10%
22 8 85 7 20 30 11 12 19 3 30 8 24
Interest 18 17 22 26 35 35 43 37 42 44 47 48 50
Depreciation 27 26 24 24 24 22 23 21 23 21 21 22 22
Profit before tax 24 -32 57 -104 -44 18 65 9 -7 4 53 4 14
Tax % 24% -44% -254% -36% -91% 30% 4% 12% -1% 28% -2% 33% -6%
19 -18 200 -66 -4 13 62 8 -7 3 54 2 15
EPS in Rs 2.06 -1.96 22.33 -7.38 -0.44 1.39 6.91 0.89 -0.75 0.28 5.84 0.26 1.66
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Dec 2012 Mar 2014 15m Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
712 1,064 929 2,162 1,382 1,470 1,537 1,692 1,858 1,979 1,854 2,153 2,334
616 914 795 1,894 1,255 1,271 1,402 1,487 1,698 1,902 1,755 1,898 2,048
Operating Profit 96 150 134 268 127 199 135 205 159 77 100 256 285
OPM % 13% 14% 14% 12% 9% 14% 9% 12% 9% 4% 5% 12% 12%
54 4,614 619 82 154 860 111 93 117 123 68 67 65
Interest 71 105 34 103 72 82 54 67 65 74 139 168 190
Depreciation 19 47 49 103 70 78 83 94 99 104 94 85 86
Profit before tax 60 4,612 669 145 139 899 109 136 112 22 -65 70 74
Tax % 7% 24% 20% 10% 22% 1% -1% 12% 30% -738% -107% 6%
56 3,513 532 130 109 892 110 120 78 180 5 65 74
EPS in Rs 9.52 589.42 89.32 14.58 12.14 99.62 12.33 13.43 8.72 20.07 0.52 7.13 8.04
Dividend Payout % 21% 86% 121% 34% 37% 2% 24% 104% 29% 0% 289% 35%
Compounded Sales Growth
10 Years: 7%
5 Years: 7%
3 Years: 5%
TTM: 18%
Compounded Profit Growth
10 Years: -4%
5 Years: -8%
3 Years: -2%
TTM: -8%
Stock Price CAGR
10 Years: 5%
5 Years: 33%
3 Years: 48%
1 Year: 225%
Return on Equity
10 Years: 6%
5 Years: 3%
3 Years: 3%
Last Year: 2%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 59 60 60 89 89 90 90 90 90 90 90 92 92
Reserves 1,313 1,571 1,415 3,068 3,143 3,073 3,167 3,069 3,158 3,317 3,365 3,469 3,425
634 473 405 1,545 1,608 606 811 902 917 1,284 1,414 1,650 1,577
293 337 273 602 641 517 595 616 1,056 743 750 627 722
Total Liabilities 2,299 2,440 2,152 5,304 5,481 4,285 4,663 4,677 5,221 5,434 5,620 5,838 5,816
306 381 394 984 1,194 564 574 651 644 617 597 556 760
CWIP 30 37 39 180 158 144 122 112 111 56 55 94 132
Investments 1,295 1,047 968 2,447 2,520 1,777 2,149 2,171 2,395 2,400 2,492 2,498 2,364
668 976 750 1,693 1,609 1,801 1,818 1,743 2,072 2,361 2,476 2,689 2,561
Total Assets 2,299 2,440 2,152 5,304 5,481 4,285 4,663 4,677 5,221 5,434 5,620 5,838 5,816

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
11 -3 207 83 412 66 40 138 283 -283 242 -36
901 3,999 305 -1,062 -883 433 -166 63 -276 19 -183 -61
-962 -3,498 -802 1,571 -67 -707 123 -204 -49 251 11 108
Net Cash Flow -50 497 -290 592 -538 -208 -3 -3 -42 -13 70 11

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 99 94 101 117 143 112 138 141 161 239 257 256
Inventory Days 98 80 110 113 204 126 197 189 254 170 168 155
Days Payable 134 127 133 148 234 183 212 200 271 213 220 166
Cash Conversion Cycle 63 47 77 82 112 55 123 130 144 196 205 244
Working Capital Days 131 100 97 120 110 150 178 150 162 231 261 292
ROCE % 9% 11% 9% 6% 5% 24% 4% 5% 4% 2% 2% 5%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
29.60% 30.60% 30.37% 31.08% 30.90% 28.28% 28.08% 27.79% 27.39% 25.88% 25.86% 25.84%
19.85% 19.66% 21.21% 21.43% 18.98% 18.85% 16.72% 17.25% 19.45% 24.57% 26.71% 30.08%
21.08% 18.82% 16.63% 15.07% 18.44% 17.88% 19.60% 19.50% 19.02% 17.66% 18.17% 18.24%
0.00% 0.00% 0.00% 0.40% 0.40% 0.40% 0.40% 0.40% 0.39% 0.39% 0.39% 0.01%
29.47% 30.92% 31.79% 32.05% 31.29% 34.60% 35.22% 35.06% 33.75% 31.52% 28.87% 25.83%
No. of Shareholders 1,25,5531,33,1901,34,7181,30,6821,23,9641,20,9161,12,7751,01,63891,18284,69591,91796,009

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls